(NASDAQ: LNTH) Lantheus Holdings's forecast annual revenue growth rate of 9.57% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 4.42%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.4%.
Lantheus Holdings's revenue in 2025 is $1,533,910,000.On average, 7 Wall Street analysts forecast LNTH's revenue for 2025 to be $108,669,448,509, with the lowest LNTH revenue forecast at $106,331,110,426, and the highest LNTH revenue forecast at $111,870,180,578. On average, 6 Wall Street analysts forecast LNTH's revenue for 2026 to be $121,968,489,569, with the lowest LNTH revenue forecast at $114,692,100,233, and the highest LNTH revenue forecast at $134,111,372,138.
In 2027, LNTH is forecast to generate $138,879,943,867 in revenue, with the lowest revenue forecast at $125,037,541,184 and the highest revenue forecast at $150,922,371,300.